1. Home
  2. INSG vs ICCC Comparison

INSG vs ICCC Comparison

Compare INSG & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inseego Corp.

INSG

Inseego Corp.

HOLD

Current Price

$3.01

Market Cap

74.5M

ML Signal

HOLD

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

SELL

Current Price

$11.00

Market Cap

88.9M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
INSG
ICCC
Founded
1996
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
74.5M
88.9M
IPO Year
2000
1995

Fundamental Metrics

Financial Performance
Metric
INSG
ICCC
Price
$3.01
$11.00
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $9.17
N/A
AVG Volume (30 Days)
★ 230.9K
11.9K
Earning Date
11-04-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 53.85
EPS
N/A
★ 0.51
Revenue
★ $313,832,000.00
$26,493,169.00
Revenue This Year
N/A
N/A
Revenue Next Year
$10.21
N/A
P/E Ratio
★ N/A
$21.94
Revenue Growth
N/A
★ 51.64
52 Week Low
$3.30
$4.67
52 Week High
$21.90
$12.10

Technical Indicators

Market Signals
Indicator
INSG
ICCC
Relative Strength Index (RSI) 32.52 58.16
Support Level N/A $9.47
Resistance Level $4.68 $11.38
Average True Range (ATR) 0.40 0.48
MACD -0.14 0.09
Stochastic Oscillator 0.49 65.65

Price Performance

Historical Comparison
INSG
ICCC

About INSG Inseego Corp.

Inseego Corp is involved in the design and development of fixed and mobile wireless solutions (4G and 5G NR), Industrial Internet of Things, and cloud solutions for enterprises, service providers, small and medium-sized businesses, governments, and consumers around the globe. Its products and services include intelligent mobile hotspots, wireless routers for IoT applications, USB modems, integrated telematics and mobile tracking devices, which are supported by application software and cloud services designed to enable customers to analyze data insights and configure and manage their hardware easily. It generates maximum revenue from the United States and Canada. The company also has a presence in Europe (including the United Kingdom).

About ICCC ImmuCell Corporation

ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.

Share on Social Networks: